• Search for KOL in rare disease environment and making the first contacts with them in regard to international medical/marketing programs for orphan drugs. 

• Finding the right clinical trial sites

• Assisting in market access.

• Assisting with ATU implementation in France.

• Establishing first contacts with patient organisations.

​